Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor
Open Access
- 1 September 2003
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 8 (3) , 467-474
- https://doi.org/10.1016/s1525-0016(03)00186-2
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in HumansCirculation, 2002
- Short-term administration of basic fibroblast growth factor enhances coronary collateral development without exacerbating atherosclerosis and balloon injury–induced vasoproliferation in atherosclerotic rabbits with acute myocardial infarctionJournal of Laboratory and Clinical Medicine, 2002
- Myocardial Regeneration Therapy for Heart FailureCirculation, 2002
- Prolactin is a component of the human synovial liquid and modulates the growth and chondrogenic differentiation of bone marrow-derived mesenchymal stem cellsMolecular and Cellular Endocrinology, 2002
- Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritisArthritis & Rheumatism, 2002
- Human Mesenchymal Stem Cells Maintain Transgene Expression during Expansion and DifferentiationMolecular Therapy, 2001
- Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cellsJournal of Clinical Investigation, 2001
- Analysis of costs associated with CABG and PTCAThe Annals of Thoracic Surgery, 1996
- Chronic Aspirin Treatment Affects Collagen Deposition in Non-infarcted Myocardium During Remodeling after Coronary Artery Ligation in the RatJournal of Molecular and Cellular Cardiology, 1995
- Early and late remodeling of the left ventricle after acute myocardial infarctionThe American Journal of Cardiology, 1984